Romano Francesco, Vingopoulos Filippos, Yuan Melissa, Ding Xinyi, Garcia Mauricio, Ploumi Ioanna, Rodriguez Jocelyn, Garg Itika, Tracy Jack H, Bannerman Augustine, Choi Hanna, Stettler Isabella, Bennett Cade, Overbey Katherine M, Laìns Inês, Kim Leo A, Vavvas Demetrios G, Husain Deeba, Miller Joan W, Miller John B
Harvard Retinal Imaging Lab, Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts; Retina Service, Department of Ophthalmology, Massachusetts Eye and Ear, Boston, Massachusetts.
Harvard Retinal Imaging Lab, Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts; Byers Eye Institute, Department of Ophthalmology, Stanford University School of Medicine, Palo Alto, California.
Ophthalmol Retina. 2024 Dec;8(12):1140-1150. doi: 10.1016/j.oret.2024.06.005. Epub 2024 Jun 13.
To investigate the relationships between contrast sensitivity (CS), choriocapillaris perfusion, and other structural OCT biomarkers in dry age-related macular degeneration (AMD).
Cross-sectional, observational study.
One hundred AMD eyes (22 early, 52 intermediate, and 26 late) from 74 patients and 45 control eyes from 37 age-similar subjects.
All participants had visual acuity (VA) assessment, quantitative CS function (qCSF) testing, macular OCT, and 6 × 6-mm swept-source OCT angiography scans on the same day. OCT volumes were analyzed for subretinal drusenoid deposits and hyporeflective drusen cores, and to measure thickness of the outer nuclear layer. OCT angiography scans were utilized to calculate drusen volume and inner choroid flow deficit percentage (IC-FD%), and to measure the area of choroidal hypertransmission defects (HTDs). Inner choroid flow deficit percentage was measured from a 16-μm thick choriocapillaris slab after compensation and binarization with Phansalkar's method. Generalized linear mixed-effects models were used to evaluate the associations between functional and structural variables.
To explore the associations between qCSF-measured CS, IC-FD%, and various AMD imaging biomarkers.
Age-related macular degeneration exhibited significantly reduced qCSF metrics eyes across all stages compared with controls. Univariate analysis revealed significant associations between various imaging biomarkers, reduced qCSF metrics, and VA in both groups. Multivariate analysis confirmed that higher IC-FD% in the central 5 mm was significantly associated with decreases in all qCSF metrics in AMD eyes (β = -0.74 to -0.25, all P < 0.05), but not with VA (P > 0.05). Outer nuclear layer thickness in the central 3 mm correlated with both VA (β = 2.85, P < 0.001) and several qCSF metrics (β = 0.01-0.90, all P < 0.05), especially in AMD eyes. Further, larger HTD areas were associated with decreased VA (β = -0.89, P < 0.001) and reduced CS at low-intermediate frequencies across AMD stages (β = -0.30 to -0.29, P < 0.001).
The significant association between IC-FD% in the central 5 mm and qCSF-measured CS reinforces the hypothesis that decreased macular choriocapillaris perfusion contributes to visual function changes in AMD, which are more pronounced in CS than in VA.
FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
研究干性年龄相关性黄斑变性(AMD)中对比敏感度(CS)、脉络膜毛细血管灌注与其他光学相干断层扫描(OCT)结构生物标志物之间的关系。
横断面观察性研究。
来自74例患者的100只AMD患眼(22只早期、52只中期和26只晚期)以及来自37名年龄相仿受试者的45只对照眼。
所有参与者在同一天进行视力(VA)评估、定量对比敏感度功能(qCSF)测试、黄斑OCT以及6×6毫米扫频源OCT血管造影扫描。分析OCT容积以检测视网膜下类玻璃膜疣沉积物和低反射性玻璃膜疣核心,并测量外核层厚度。利用OCT血管造影扫描计算玻璃膜疣体积和脉络膜内层血流缺失百分比(IC-FD%),并测量脉络膜高透过缺陷(HTDs)面积。采用Phansalkar方法进行补偿和二值化后,从16微米厚的脉络膜毛细血管层测量IC-FD%。使用广义线性混合效应模型评估功能和结构变量之间的关联。
探讨qCSF测量的CS、IC-FD%与各种AMD成像生物标志物之间的关联。
与对照组相比,各阶段的AMD患眼qCSF指标均显著降低。单因素分析显示,两组中各种成像生物标志物、qCSF指标降低与VA之间均存在显著关联。多因素分析证实,AMD患眼中中央5毫米范围内较高的IC-FD%与所有qCSF指标降低显著相关(β=-0.74至-0.25,均P<0.05),但与VA无关(P>0.05)。中央3毫米范围内的外核层厚度与VA(β=2.85,P<0.001)和多个qCSF指标(β=0.01-0.90,均P<0.05)相关,尤其是在AMD患眼中。此外,更大的HTD面积与VA降低(β=-0.89,P<0.001)以及AMD各阶段中低中频CS降低相关(β=-0.30至-0.29,P<0.001)。
中央5毫米范围内的IC-FD%与qCSF测量的CS之间的显著关联强化了以下假设,即黄斑脉络膜毛细血管灌注减少导致AMD患者视觉功能改变,这种改变在CS方面比在VA方面更明显。
在本文末尾的脚注和披露中可能会找到专有或商业披露信息。